Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
LPM787000048 in Alzheimer Disease: NCT07292233 Clinical Landscape Report 2026
15 October 2026
NCT07292233 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Picankibart in Arthritis, Psoriatic: NCT07295509 Clinical Landscape Report 2026
15 October 2026
NCT07295509 clinical landscape for Arthritis, Psoriatic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ORKA-001 in Plaque psoriasis: NCT07290569 Clinical Landscape Report 2026
15 October 2026
NCT07290569 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Roflumilast in Dermatitis, Atopic: NCT07297602 Clinical Landscape Report 2026
15 October 2026
NCT07297602 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tretinoin in acute leukemia: NCT07296445 Clinical Landscape Report 2026
15 October 2026
NCT07296445 clinical landscape for acute leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Bleximenib in Acute Myeloid Leukemia: NCT07295951 Clinical Landscape Report 2026
15 October 2026
NCT07295951 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Orelabrutinib in Multiple Sclerosis, Secondary Progressive: NCT07299019 Clinical Landscape Report 2026
15 October 2026
NCT07299019 clinical landscape for Multiple Sclerosis, Secondary Progressive: endpoints, sponsor, phase, geography, readouts, asset context and development w…
9 min read
ENV-294 in Dermatitis, Atopic: NCT07298395 Clinical Landscape Report 2026
15 October 2026
NCT07298395 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Cannabidiol in Dermatitis, Atopic: NCT07301658 Clinical Landscape Report 2026
15 October 2026
NCT07301658 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
AK152 in Alzheimer Disease: NCT07301502 Clinical Landscape Report 2026
15 October 2026
NCT07301502 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Chidamide in Acute Myeloid Leukemia: NCT07304232 Clinical Landscape Report 2026
15 October 2026
NCT07304232 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tacrolimus in Acute Myeloid Leukemia: NCT07302776 Clinical Landscape Report 2026
15 October 2026
NCT07302776 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.